MarineMax, Inc.
NYSE:HZOSpecialty Retail
+$1.29 today
- Market cap
- $1.17B
- Beta
- 1.60
- P/E (TTM)
- -11.9
- EPS (TTM)
- -$2.89
Volume 0.93M
Average 0.34M
HZO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
MarineMax, Inc.NYSE: HZO
Research & Development · Q2 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 0 | — |
| FY2024 | 2024-09-30 | 0 | — |
| FY2023 | 2023-09-30 | 0 | — |
| FY2022 | 2022-09-30 | 0 | — |
| FY2021 | 2021-09-30 | 0 | — |
Research & Development vs competitors
How HZO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for HZO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ZKHZKH Group Limited | LTM Mar 2026 | CN¥155.25M CNY | -8.3% | -11.7% | 1.7% |
| LTM Mar 2026 | CN¥153.01M CNY | +47.3% | +1.1% | 3.4% | |
| LTM Mar 2026 | $36.27M USD | -4.7% | -10.9% | 17.8% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | MX$0 MXN | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM May 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM May 2026 | $0 USD | — | — | 0.0% | |
| LTM May 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding HZO) | — | -4.7% | -10.9% | 0.0% | |
Competitors are the stored peer set for HZO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 2.06B | 2.31B | 2.39B | 2.43B | 2.31B |
| Cost of Revenue | 1.4B | 1.5B | 1.56B | 1.63B | 1.56B |
| Gross Profit | 659.43M | 805.75M | 835.33M | 801.2M | 750.23M |
| Gross Margin | 32.0% | 34.9% | 34.9% | 33.0% | 32.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 449.97M | 540.55M | 632.16M | 676M | 647.16M |
| Operating Expenses | 449.97M | 540.55M | 634.53M | 672.97M | 647.16M |
| Depreciation & Amortization | 15.61M | 19.42M | 41.03M | 44.49M | 49.32M |
| EBITDA | 225.07M | 290.42M | 244.21M | 169.68M | 83.34M |
| EBITDA Margin | 10.9% | 12.6% | 10.2% | 7.0% | 3.6% |
| Operating Income | 209.46M | 265.2M | 200.8M | 128.23M | 103.07M |
| Operating Margin | 10.2% | 11.5% | 8.4% | 5.3% | 4.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.67M | 3.28M | 53.37M | 73.9M | 71.16M |
| Other Income / Expenses | (3.67M) | (3.28M) | (53.37M) | (73.9M) | (140.21M) |
| Income Before Tax | 205.79M | 261.92M | 147.44M | 54.33M | (37.14M) |
| Pre-Tax Margin | 10.0% | 11.3% | 6.2% | 2.2% | -1.6% |
| Income Tax Expense | 50.82M | 63.93M | 37.96M | 15.59M | (6.38M) |
| Net Income | 154.98M | 197.99M | 109.28M | 38.07M | (31.63M) |
| Net Margin | 7.5% | 8.6% | 4.6% | 1.6% | -1.4% |
| EPS (Basic) | 7.04 | 9.12 | 5.00 | 1.71 | (1.43) |
| EPS (Diluted) | 6.78 | 8.84 | 4.87 | 1.65 | (1.43) |
| Weighted Avg Shares | 22.01M | 21.71M | 21.85M | 22.27M | 22.05M |
| Weighted Avg Shares (Diluted) | 22.86M | 22.4M | 22.43M | 23.01M | 22.05M |
MarineMax, Inc.
NYSE:HZO
Intrinsic Alpha fair value
Locked
Current Price
$52.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.